Embolx, Inc., announced that it has entered into a Securities Purchase Agreement with PAID, Inc. for issue of senior secured convertible note for gross proceeds of $1.629 million on October 19, 2022. The note is purchased at a 20% original issue discount and is subject to a 9-month maturity, after which, if unpaid, will then carry a 20% interest rate. The company will issue five-year warrants.

The Company has the option to convert the note into shares of common stock of company. Under the securities purchase agreement, the company has a right to purchase additional shares on the same terms for a total potential investment amount of $2 million. The issue of securities in reliance upon an exemption from securities registration requirements of the Securities Act of 1933, as amended, afforded by the provisions of Section 4(a)(2) and/or Rule 506(b) of Regulation D promulgated thereunder by the U.S. Securities and Exchange Commission.